Location: Home
  • search
  • go
  • Relate News
  • 3/12/2025Akeso Initiates Phase III Trial of Ivonescimab Plus Chemotherapy for m...
  • 3/11/2025Chinese Scientists Develop Potential Vaccine to Prevent Stroke and Hea...
  • 3/4/2025Insilico and Tenacia Announce Research Collaboration for CNS Drug Disc...
  • 2/28/2025NMPA Approves Multiple Drugs for Cancer, Cardiovascular, and Liver Dis...
  • 2/28/2025SciClone Secures Rights to Eisai's Tasurgratinib for Greater China
  • 2/25/2025Pfizer to Study China-Originated Ivonescimab in ADC Combo Under Summit...
  • 2/25/2025BioCity's SC0062 Achieves Primary Endpoint in Phase 2 DKD Trial
  • 2/21/2025NMPA Announces Package Insert Revision of Fluorouracil Injection
  • 2/20/2025Chimigen Secures CNY100M+ in Pre-A Financing to Advance Cancer and Hep...
  • 2/14/2025NMPA Approves SciClone's Vibativ for Drug-Resistant Gram-Positive Infe...
  • 2/14/2025China's Health Insurance Premiums Reached $134B in 2024, Up 8.2% YoY
  • 2/13/2025Jiangsu Recbio's Novel HPV Vaccine Trial Approved in China
  • 2/12/2025CSPC Granted NMPA Approval for Herpes Zoster mRNA Vaccine Clinical Tri...
  • 2/11/2025China's Digital Health Sector Poised for Growth Amid Data Security Con...
  • 2/7/2025NMPA Announces Package Insert Revision of Gemifloxacin Mesylate Tablet...
  • 2/6/2025GSK Faces Vaccine Challenges in China Amid Market Pressures
  • 2/6/2025Merck Halts HPV Vaccine Supply: What It Says about China Market (EGGI)
  • 2/5/2025Merck Faces Growing Challenges in China as Gardasil Sales Stall  
  • 1/28/2025Chinese Researchers Develop Promising Nanovaccine for Breast Cancer Tr...
  • 1/23/2025CDE Issues the Guidelines for Writing Clinical-Related Information in ...
  • 1/23/2025CDE Issues the Technical Guidelines for Pharmaceutical Studies of Monk...
  • 1/23/2025CDE Issues the Technical Guidelines for Non-Clinical Research of Proph...
  • 1/21/2025NiKang Does First Patient in a Phase 1b/2 Study of NKT2152 in Combo fo...
  • 1/14/2025CR Pharma Partners with NAMI to Explore Palbociclib for Alzheimer's Tr...
  • 1/13/2025Vertex, Zai Lab Enter Asian Licensing Pact for Povetacicept
  • 1/13/2025Akeso Launches Phase 3 Trial for Ivonescimab (AK112)
  • 1/13/2025CirCode Receives NMPA IND Approval for HM2002 Injection
  • 1/13/2025Gentize Biopharma Secures ~CNY 100M in Pre-A Financing to Advance Vacc...
  • 1/12/2025Vertex and Zai Lab Announce Strategic Deal for Povetacicept in Greater...
  • 1/12/2025Moderna Navigates Cautious Expansion Into China Amid Geopolitical Tens...
  • Page:3/73 Total number of articles:2167: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group